default author photo

Laura Diehl

Goethe University Frankfurt - Institute for Transfusion Medicine and Immunohematology

Frankfurt

Germany

SCHOLARLY PAPERS

1

DOWNLOADS

31

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

The Immune Checkpoint ICOSLG is a Relapse-Predicting Biomarker and Therapeutic Target in Infant t(4;11) Acute Lymphoblastic Leukemia

Number of pages: 32 Posted: 18 Mar 2022
Goethe University Frankfurt - Diagnostic Center of Acute Leukemia (DCAL), Goethe University Frankfurt - Diagnostic Center of Acute Leukemia (DCAL), Goethe University Frankfurt - Diagnostic Center of Acute Leukemia (DCAL), Goethe University Frankfurt - Diagnostic Center of Acute Leukemia (DCAL), Schleswig-Holstein University - Department of Pediatrics, Schleswig-Holstein University - Department of Pediatrics, Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology, AP-HP Hôpital R. Debré - Département de Génétique, AP-HP Hôpital R. Debré - Département de Génétique, University of Milano Bicocca - Centro Ricerca M. Tettamanti, Paediatrics, University of Milan - Bicocca - Centro Ricerca Tettamanti, Pediatrics, University of Milano-Bicocca - Paediatrics, University of Milano-Bicocca - Centre of Biostatistics for Clinical Epidemiology, Goethe University Frankfurt - Institute for Transfusion Medicine and Immunohematology, Goethe University Frankfurt - Institute for Transfusion Medicine and Immunohematology, Goethe University Frankfurt - Diagnostic Center of Acute Leukemia (DCAL) and Goethe University Frankfurt - Institute of Pharmaceutical Chemistry
Downloads 31 (1,304,549)

Abstract:

Loading...

ICOSLG, EGR3, t(4, 11), MLL/KMT2A, AF4/AFF1, KMT2A::AFF1, MLL::AF4, infant ALL, relapse, Immune checkpoint